Johnson & Johnson (JNJ) Tuesday reported a profit for the first-quarter rose 6.9 percent from last year, reflecting continued recovery in medical devices and strength in its pharmaceutical business. Quarterly sales rose 7.9 percent. Both adjusted earnings per share and quarterly revenues topped analysts' expectations.
Looking ahead for fiscal year 2021, the company now expects adjusted earnings per share to be in the range of $9.42 - $9.57, compared to the prior estimation of $9.40 - $9.60. Analysts expect annual earnings of $9.50 per share.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com